All influenza articles
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsA step toward diagnosing the flu with your tongue
A new molecular sensor has been designed to release a thyme flavor when it encounters the influenza virus. Researchers plan to incorporate this type of low-tech sensor into gum or lozenges to increase at-home screenings and potentially prevent pre-symptomatic transmission of the disease.
-
NewsBeyond viruses: Expanding the fight against infectious diseases
The newly renamed Gladstone Infectious Disease Institute has broadened its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.
-
NewsGray seals perplex scientists with lack of response to flu infection
Something strange happens when two kinds of seals living in the waters around Cape Cod get infected with influenza – harbor seals get sick but gray seals don’t. This perplexing phenomenon led scientists to investigate if a difference in a piece of the immune system called cytokines could be responsible for this difference.
-
NewsFlu fighters: researchers take a closer look at immune response to influenza
Researchers sought to identify which immune cells in pigs have receptors that are most reactive to influenza. They accomplished this by customizing a technology called single-cell RNA sequencing for pigs to learn more about how a body’s cells operate at a highly detailed level.
-
NewsNovel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
Non-pharmaceutical interventions such as masking and distancing targeted towards SARS-CoV-2 during the pandemic also decreased circulation rates of and population immunity to common respiratory pathogens in children, a new study shows.
-
NewsNational study urges expanded vaccine screening in emergency departments
About 49% of people are unaware of one or more vaccines recommended for them. Further, 86% have not received one or more of these vaccines, according to the first national comprehensive vaccine surveillance study conducted in emergency departments.
-
NewsNew drug combo outperforms Tamiflu in fighting flu (and chocolate is the key)
Scientists have unveiled a new drug pairing - including a compound found in chocolate - that outperforms Tamiflu, the most widely used anti-influenza medication, against even the deadliest flu strains, including avian and swine flu.
-
NewsStudy highlights the severity of acute necrotizing encephalopathy in kids with the flu
For a small subset of children, influenza can trigger a rare but serious complication called influenza-associated acute necrotizing encephalopathy (ANE). Now, findings of a multicenter study suggest that ANE is often fatal in these children — despite intensive treatment.
-
NewsStudy of water bodies frequented by wild birds reveals presence of antimicrobial resistance genes in nine in 10 samples
The first UK study to monitor antimicrobial resistance and influenza viruses in water bodies has revealed that 92% of samples contained genes for resistance to colistin, an antibiotic of last resort.
-
NewsImmunity to seasonal flu protects against severe illness from bird flu in ferrets
A study in ferrets — which have remarkably similar respiratory systems to humans — suggests that widespread immunity to H1N1 seasonal influenza virus may explain why exposure to H5N1 bird flu causes only mild symptoms in humans.
-
NewsSwiss genome of the 1918 influenza virus reconstructed
Researchers have decoded the genome of the virus responsible for the 1918–1920 influenza pandemic in Switzerland, revealing that it had already developed key adaptations to humans at the outset of the deadliest influenza pandemic in history.
-
NewsTiny chip speeds up antibody mapping for faster vaccine design
By analyzing just a drop of blood, this microchip gives researchers quicker-than-ever insight into how a person’s antibodies are interacting with a virus or other pathogen.
-
NewsChameleon plant polysccharide targets acute pneumonia with H1N1 and MRSA coinfection
A new study discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.
-
NewsResearchers reveal remarkable antimicrobial activity in hydrogen boride nanosheets
Hydrogen boride (HB) nanosheets represent an exciting new frontier in the search for technologies that can combat microbes in everyday settings. Researchers discovered that they exhibit excellent antibacterial, antiviral, and antifungal properties.
-
NewsResearchers pioneer novel, needle-free, live-attenuated influenza vaccines with broad protection
Researchers have achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV).
-
NewsInfluenza virus hacks cell’s internal system
The influenza virus manipulates the body’s gene regulation system to accelerate its own spread, according to researchers. Their study shows that an already approved drug could help strengthen immune defenses—though its effect in humans remains to be confirmed.
-
NewsGlobal study finds single-dose baloxavir reduces household influenza transmission
A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza management.
-
NewsEradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25.
-
NewsNew COVID-flu vaccine platform could provide broad, lasting protection
Researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains.